Profile
Ami Shah Brown is currently a Senior Vice President-Regulatory Affairs at Icosavax, Inc. Prior to this, she worked as a Senior Vice President-Regulatory Affairs at Inovio Pharmaceuticals, Inc. from 2011 to 2022.
She also worked as an Assistant Professor at George Washington University.
Dr. Brown received her undergraduate degree from the University of Pennsylvania, her graduate degree from Emory University, and her doctorate from Johns Hopkins Bloomberg School of Public Health.
Ami Shah Brown active positions
| Companies | Position | Start |
|---|---|---|
| ICOSAVAX, INC. | General Counsel | - |
Former positions of Ami Shah Brown
| Companies | Position | End |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | General Counsel | 01/03/2022 |
| George Washington University | Corporate Officer/Principal | - |
Training of Ami Shah Brown
| University of Pennsylvania | Undergraduate Degree |
| Emory University | Graduate Degree |
| Johns Hopkins Bloomberg School of Public Health | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Ami Shah Brown
